Novartis Earnings Miss Forecasts

Swiss Drug Maker Boosts Efforts to Lift Sales

Novartis AG is exploring "unique structures" that may include joint ventures or business swaps for its smaller businesses, Chief Executive Joe Jimenez said as the Swiss pharmaceutical giant reported fourth-quarter earnings that narrowly missed expectations.

Basel-based Novartis is in the middle of a roughly year-old review of its operations that aims to refocus the company on areas in which it has scale to compete...